Author | David F. McDermott, MD | OncLive

Author | David F. McDermott, MD

Articles

Dr. McDermott on VEGF/PD-1 Inhibition in RCC

March 05, 2020

Video

David F. McDermott, MD, discusses the research behind combining VEGF inhibitors with PD-1/PD-L1 inhibitors in renal cell carcinoma treatment.

Dr. McDermott on Toxicities of Immunotherapy Combinations in RCC

February 12, 2020

Video

David F. McDermott, MD, discusses the toxicities associated with immunotherapy combinations in renal cell carcinoma.

Dr. McDermott on the Use of PD-1 Inhibitor Combos in mRCC

January 08, 2020

Video

David F. McDermott, MD, discusses the use of PD-1 inhibitors in combination with VEGF inhibitors and CTLA-4 inhibitors in metastatic renal cell carcinoma.

Dr. McDermott on TKI/Immunotherapy Combinations in RCC

November 12, 2019

Video

David F. McDermott, MD, discusses the combination of VEGF TKIs and PD-1 inhibitors in advanced renal cell carcinoma.

x